AMAT vs NKE: Which Is the Better Buy?

Side-by-side comparison of Applied Materials, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-20.
Applied Materials, Inc. Β· Technology
$406.91
-12.0% upside to fair value
Grade B- High Quality
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+38.4% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
NKE has more upside to fair value (+38.4%). NKE trades at a lower forward P/E (27.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMAT NKE
Current Price $406.91 $42.62
Fair Value Estimate $358.00 $58.98
Upside to Fair Value -12.0% +38.4%
Market Cap $322.9B $63.0B
Forward P/E 30.3x 27.9x
EV / EBITDA 30.2x 20.7x
Price / Sales 10.2x 1.4x
Price / FCF 51.6x 19.4x
Revenue Growth YoY +11.0% -9.8%
Gross Margin 49.9% 42.7%
Operating Margin 31.9% 8.0%
Return on Equity 47.0% 24.4%
Dividend Yield 0.45% 3.8%
FCF Yield 1.94% 5.2%
Analyst Consensus Strong Buy Buy
Investment Thesis
AMAT β€” Applied Materials, Inc.
Applied Materials is the world's leading semiconductor and display equipment company, and the May 14 Q2 fiscal 2026 print materially strengthened the operating story. Revenue grew 11 percent year over year to a record $7.91 billion, non-GAAP earnings per share of $2.86 beat consensus of $2.68, and management guided Q3 to a record $8.95 billion in revenue with non-GAAP earnings per share of $3.36 …
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric AMAT NKE
Zone Low $268.50 $44.23
Zone High $304.30 $50.13
In Buy Zone? No Yes
← AMAT Research    NKE Research β†’    All Research